Olena Kamenyeva
Staff scientist
Biological Imaging Section, Research Technology Branch
National Institute of Allergy and Immune Diseases, National Institutes of Health (NIAID-NIH)
Bethesda MD, USA
Research Interest: Intravital microscopy of infection spread and host defense, molecular immunology, vascular biology, innate immunity, and computational imaging, TB granulomas, MRSA infection, and immunotherapy of ovarian cancer.
Olena Kamenyeva
Sectional Editor (Molecular Immunology, Immunother
Staff scientist
Biological Imaging Section, Research Technology Branch
National Institute of Allergy and Immune Diseases, National Institutes of Health (NIAID-NIH)
Bethesda MD, USA
Research Interest: Intravital microscopy of infection spread and host defense, molecular immunology, vascular biology, innate immunity, and computational imaging, TB granulomas, MRSA infection, and immunotherapy of ovarian cancer.
Michael Maes
Department of Psychiatry
Chulalongkorn University, Bangkok
Research Interest: Biomarkers and pathways of psychiatric disorders, such as major depression, chronic fatigue syndrome, bipolar disorder and schizophrenia, and (neuro-)immune disorders, including Parkinson’s disorder, multiple sclerosis, lupus erythematosus, stroke, rheumatoid arthritis and Alzheimer’s disease
Michael Maes
Sectional Editor (neuro-immune disorders)
Department of Psychiatry
Chulalongkorn University, Bangkok
Research Interest: Biomarkers and pathways of psychiatric disorders, such as major depression, chronic fatigue syndrome, bipolar disorder and schizophrenia, and (neuro-)immune disorders, including Parkinson’s disorder, multiple sclerosis, lupus erythematosus, stroke, rheumatoid arthritis and Alzheimer’s disease
Idit Shachar
Idit Shachar
Sectional Editor (Cancer Immunology and autoimmune
Daolin Tang
Professor, Department of Surgery
Director, Center for DAMP Biology
University of Texas Southwestern Medical Center
USA
Dr. Daolin Tang is currently a Professor in the Department of Surgery at UT Southwestern Medical Center. He earned his medical degree from the Norman Bethune College of Medicine and his Ph.D. from the Xiangya School of Medicine, both in China. Dr. Tang's research focuses on the molecular mechanisms of diseases, particularly pancreatic cancer. His interests include immunometabolism and sepsis, the roles of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) in immunity, various forms of regulated cell death (such as ferroptosis, pyroptosis, and alkaliptosis), and autophagy. He has authored nearly 200 publications and has received numerous awards, including being named a Hillman Fellow for Innovative Cancer Research and receiving a Research Scholar Award from the American Cancer Society.
Daolin Tang
Sectional Editor (inflammatory diseases,cell death
Professor, Department of Surgery
Director, Center for DAMP Biology
University of Texas Southwestern Medical Center
USA
Dr. Daolin Tang is currently a Professor in the Department of Surgery at UT Southwestern Medical Center. He earned his medical degree from the Norman Bethune College of Medicine and his Ph.D. from the Xiangya School of Medicine, both in China. Dr. Tang's research focuses on the molecular mechanisms of diseases, particularly pancreatic cancer. His interests include immunometabolism and sepsis, the roles of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) in immunity, various forms of regulated cell death (such as ferroptosis, pyroptosis, and alkaliptosis), and autophagy. He has authored nearly 200 publications and has received numerous awards, including being named a Hillman Fellow for Innovative Cancer Research and receiving a Research Scholar Award from the American Cancer Society.
Giuseppe Andrea Sautto
Assistant Staff
Cleveland Clinic Florida Research & Innovation Center
USA
Dr. Giuseppe Andrea Sautto is an Assistant Staff member at the Cleveland Clinic Florida Research & Innovation Center. He earned his Bachelor's degree in Medical Biotechnology from the University of Milan in 2006, followed by a Master's degree in Molecular and Cellular Medical Biotechnology in 2008, and a Ph.D. in Molecular Medicine in 2012 from the Vita-Salute San Raffaele University of Milan. In 2022, he completed an MBA at the Terry College of Business, University of Georgia. Dr. Sautto's research focuses on developing next-generation vaccines and immunotherapies targeting infectious pathogens, including hepatitis C virus (HCV), influenza virus, and SARS-CoV-2. His work emphasizes the use of monoclonal antibodies as tools for novel vaccine design and therapeutic applications.
Giuseppe Andrea Sautto
Sectional Editor (Monoclonal antibody engineering,
Assistant Staff
Cleveland Clinic Florida Research & Innovation Center
USA
Dr. Giuseppe Andrea Sautto is an Assistant Staff member at the Cleveland Clinic Florida Research & Innovation Center. He earned his Bachelor's degree in Medical Biotechnology from the University of Milan in 2006, followed by a Master's degree in Molecular and Cellular Medical Biotechnology in 2008, and a Ph.D. in Molecular Medicine in 2012 from the Vita-Salute San Raffaele University of Milan. In 2022, he completed an MBA at the Terry College of Business, University of Georgia. Dr. Sautto's research focuses on developing next-generation vaccines and immunotherapies targeting infectious pathogens, including hepatitis C virus (HCV), influenza virus, and SARS-CoV-2. His work emphasizes the use of monoclonal antibodies as tools for novel vaccine design and therapeutic applications.
Yongqiang Feng
Yongqiang Feng
Sectional Editor (Immunological tolerance, Transcr
Wuhan Xiao
Wuhan Xiao
Sectional Editor (Signal transduction, Regulatory
Christian Secchi
Dr. Christian Secchi
Researcher
University of California, San Diego (UCSD)
San Diego, USA
Dr. Christian Secchi is a researcher in pre-clinical drug discovery at the University of California, San Diego (UCSD), USA. His work focuses on identifying and validating molecular targets and PD/PoC models for treating chronic disorders.
Previously, Dr. Secchi was a postdoctoral scholar at UCSD and the La Jolla Institute for Allergy and Immunology, where he worked on autoimmune diseases (Rheumatoid Arthritis, Lupus), reproductive disorders (PCOS), and cancer. His Ph.D. research explored T cell signaling, oxidative stress responses, and telomere regulation in hematologic diseases.
With expertise in gene and cell therapy, proteomics, and mass spectrometry, Dr. Secchi has extensive experience in mentoring, project management, and translational research.
Christian Secchi
Sectional Editor (Inflammation, Autoimmune disease
Dr. Christian Secchi
Researcher
University of California, San Diego (UCSD)
San Diego, USA
Dr. Christian Secchi is a researcher in pre-clinical drug discovery at the University of California, San Diego (UCSD), USA. His work focuses on identifying and validating molecular targets and PD/PoC models for treating chronic disorders.
Previously, Dr. Secchi was a postdoctoral scholar at UCSD and the La Jolla Institute for Allergy and Immunology, where he worked on autoimmune diseases (Rheumatoid Arthritis, Lupus), reproductive disorders (PCOS), and cancer. His Ph.D. research explored T cell signaling, oxidative stress responses, and telomere regulation in hematologic diseases.
With expertise in gene and cell therapy, proteomics, and mass spectrometry, Dr. Secchi has extensive experience in mentoring, project management, and translational research.
Arjun Mohan
Dr. Arjun Mohan
Clinical Associate Professor, Internal Medicine
Associate Chief Clinical Officer, Medical Specialties Oversight Team
Michigan Medicine, University of Michigan
USA
Dr. Arjun Mohan is a Clinical Associate Professor of Internal Medicine at Michigan Medicine, University of Michigan, where he also serves as the Associate Chief Clinical Officer for the Medical Specialties Oversight Team. He obtained his MBBS from J.J.M. Medical College, Davangere, India, in 2006, followed by an Internal Medicine residency at the Miller School of Medicine (2012) and a fellowship at the University at Buffalo (2015).
Dr. Mohan has been actively involved in clinical research and patient care, focusing on asthma management and pulmonary diseases. He has been an investigator in multiple clinical trials and has led expert panels to develop clinical guidelines aimed at improving research methodologies and patient care.
Research Interests
- Asthma and Respiratory Disorders – Evaluating novel therapies and improving treatment strategies
- Disease Heterogeneity – Understanding variations in asthma presentation and progression
- Predictive Models for Exacerbations – Developing AI-driven models for early diagnosis and treatment adjustments
- Clinical Trials & Pulmonary Medicine – Investigating new therapies for chronic respiratory diseases
Dr. Mohan is dedicated to advancing pulmonary medicine through clinical research, innovation, and patient-centered care.
Arjun Mohan
Sectional Editor (Inflammatory Disorders, Sarcoido
Dr. Arjun Mohan
Clinical Associate Professor, Internal Medicine
Associate Chief Clinical Officer, Medical Specialties Oversight Team
Michigan Medicine, University of Michigan
USA
Dr. Arjun Mohan is a Clinical Associate Professor of Internal Medicine at Michigan Medicine, University of Michigan, where he also serves as the Associate Chief Clinical Officer for the Medical Specialties Oversight Team. He obtained his MBBS from J.J.M. Medical College, Davangere, India, in 2006, followed by an Internal Medicine residency at the Miller School of Medicine (2012) and a fellowship at the University at Buffalo (2015).
Dr. Mohan has been actively involved in clinical research and patient care, focusing on asthma management and pulmonary diseases. He has been an investigator in multiple clinical trials and has led expert panels to develop clinical guidelines aimed at improving research methodologies and patient care.
Research Interests
- Asthma and Respiratory Disorders – Evaluating novel therapies and improving treatment strategies
- Disease Heterogeneity – Understanding variations in asthma presentation and progression
- Predictive Models for Exacerbations – Developing AI-driven models for early diagnosis and treatment adjustments
- Clinical Trials & Pulmonary Medicine – Investigating new therapies for chronic respiratory diseases
Dr. Mohan is dedicated to advancing pulmonary medicine through clinical research, innovation, and patient-centered care.
Godfred Antony Menezes
Assistant Professor
RAK College of Medical Sciences (RAKCOMS)
RAKMHSU, Ras al Khaimah
UAE
Research Interest: Serology, Diagnostic Microbiology, Antimicrobial Resistance, Genetics, Medical Microbiology, Medical Sciences
Godfred Antony Menezes
Sectional Editor (Diagnostic immunology)
Assistant Professor
RAK College of Medical Sciences (RAKCOMS)
RAKMHSU, Ras al Khaimah
UAE
Research Interest: Serology, Diagnostic Microbiology, Antimicrobial Resistance, Genetics, Medical Microbiology, Medical Sciences
Jeel Moya-Salazar
Associate Professor of Medicine
National University of San Marcos
Lima, Peru
Research Interest : Laboratory Medicine, Immunology, Molecular Biology, Biotechnology, Oncology
Jeel Moya-Salazar
Sectional Editor (Oncology and Cancer Immunology)
Associate Professor of Medicine
National University of San Marcos
Lima, Peru
Research Interest : Laboratory Medicine, Immunology, Molecular Biology, Biotechnology, Oncology
Tsvetelina Velikova
Specialist of Clinical Immunology
University Hospital Lozenetz
Kozyak 1 Str., Sofia 1407
Bulgaria
Research Interest: Molecular biology, Immunology, Microbiology, Virology, Parasitology and Genetics
Tsvetelina Velikova
Sectional Editor (Clinical Immunology)
Specialist of Clinical Immunology
University Hospital Lozenetz
Kozyak 1 Str., Sofia 1407
Bulgaria
Research Interest: Molecular biology, Immunology, Microbiology, Virology, Parasitology and Genetics
Weihua Huang
Department of Pathology
New York Medical College
USA
Research Interest: Next-generation sequencing, Genomics, Transcriptomics, Metagenomics, Metatranscriptomics, Bioinformatics, Molecular diagnostics
Weihua Huang
Sectional Editor (Molecular diagnostics)
Department of Pathology
New York Medical College
USA
Research Interest: Next-generation sequencing, Genomics, Transcriptomics, Metagenomics, Metatranscriptomics, Bioinformatics, Molecular diagnostics
M. Bilal Abid
Assistant Professor
Divisions of Hematology/Oncology & Infectious Disease
Department of Medicine
Medical College of Wisconsin
Milwaukee, Wisconsin
USA
Research Interest: Immunotherapy, CAR T-cells, Transplant Infectious Diseases, Gut Microbiome
M. Bilal Abid
Sectional Editor (Immunotherapy)
Assistant Professor
Divisions of Hematology/Oncology & Infectious Disease
Department of Medicine
Medical College of Wisconsin
Milwaukee, Wisconsin
USA
Research Interest: Immunotherapy, CAR T-cells, Transplant Infectious Diseases, Gut Microbiome
Alessandro Poggi
Dr. Alessandro Poggi
Former Health Executive
Head of UOSD Molecular Oncology and Angiogenesis
Policlinico San Martino
Genoa, Italy
Biography: Dr Alessandro Poggi has been working on cellular and tumor immunology for more than 30 years. He is authors of 211 original articles published on indexed journals and he is a reviewer of several scientific journals. Starting from his first doctoral degree in Biological Sciences (1982), he worked on leukocyte subsets. After his Post-Doctoral Fellow training at the Ludwig Cancer Institute in Lausanne, Switzerland (1985-1987), he has been appointed as Assistant Member at the IST (Immunopathology Unit) in Genoa studying natural killer cells, molecular aspects of survival of subsets of leukocytes and the role of mesenchymal stromal cells in tumor microenvironment. In 2000, he has taken his second doctoral degree in Medicine and Surgery and in 2009, he became director of the Molecular Oncology and Angiogenesis Unit at the IRCCS AOU San Martino IST (now Policlinico San Martino) in Genoa. At present, he is setting up the Digital Pathology facility to define in detail the features of tumor infiltrating lymphocytes. His main interest is to define new approaches to stimulate the innate immune response in colorectal cancer. To this aim, he has planned to made new kind of antibody drug conjugates (ADC) to target tumor cells. Indeed, these new ADC, beside killing tumor cells by themselves, can stimulate innate immune response amplifying their anti-tumor effect. The efficiency of these ADC have been tested in non conventional three dimensional cultures to avoid the use of animals according to 3R policy. These experiments have been performing co-culturing patients'-derived tumor cells and lymphocytes. This to proof the possibility of transferring preclinical results into the clinic.
Alessandro Poggi
Sectional Editor (Tumor immunology)
Dr. Alessandro Poggi
Former Health Executive
Head of UOSD Molecular Oncology and Angiogenesis
Policlinico San Martino
Genoa, Italy
Biography: Dr Alessandro Poggi has been working on cellular and tumor immunology for more than 30 years. He is authors of 211 original articles published on indexed journals and he is a reviewer of several scientific journals. Starting from his first doctoral degree in Biological Sciences (1982), he worked on leukocyte subsets. After his Post-Doctoral Fellow training at the Ludwig Cancer Institute in Lausanne, Switzerland (1985-1987), he has been appointed as Assistant Member at the IST (Immunopathology Unit) in Genoa studying natural killer cells, molecular aspects of survival of subsets of leukocytes and the role of mesenchymal stromal cells in tumor microenvironment. In 2000, he has taken his second doctoral degree in Medicine and Surgery and in 2009, he became director of the Molecular Oncology and Angiogenesis Unit at the IRCCS AOU San Martino IST (now Policlinico San Martino) in Genoa. At present, he is setting up the Digital Pathology facility to define in detail the features of tumor infiltrating lymphocytes. His main interest is to define new approaches to stimulate the innate immune response in colorectal cancer. To this aim, he has planned to made new kind of antibody drug conjugates (ADC) to target tumor cells. Indeed, these new ADC, beside killing tumor cells by themselves, can stimulate innate immune response amplifying their anti-tumor effect. The efficiency of these ADC have been tested in non conventional three dimensional cultures to avoid the use of animals according to 3R policy. These experiments have been performing co-culturing patients'-derived tumor cells and lymphocytes. This to proof the possibility of transferring preclinical results into the clinic.
Derry K Mercer
Derry K. Mercer
Principal Scientist
NovaBiotics Limited
Aberdeen, UK
Research Interests:
Antimicrobial peptides, antifungal agents, host defense peptides, innate immunity, antimicrobial resistance
Biography:
Dr. Derry K. Mercer is the Principal Scientist at NovaBiotics Ltd., a biotechnology company based in Aberdeen, UK. His research focuses on the development of novel antimicrobial and antifungal therapies, particularly those derived from host defense peptides and innate immune mechanisms. Dr. Mercer has contributed to the understanding of antimicrobial susceptibility testing and the therapeutic potential of antimicrobial peptides. He has co-authored publications on topics such as antimicrobial susceptibility testing of peptides and the role of host defense peptides in antifungal therapy.
Derry K Mercer
Sectional Editor (Innate immune system)
Derry K. Mercer
Principal Scientist
NovaBiotics Limited
Aberdeen, UK
Research Interests:
Antimicrobial peptides, antifungal agents, host defense peptides, innate immunity, antimicrobial resistance
Biography:
Dr. Derry K. Mercer is the Principal Scientist at NovaBiotics Ltd., a biotechnology company based in Aberdeen, UK. His research focuses on the development of novel antimicrobial and antifungal therapies, particularly those derived from host defense peptides and innate immune mechanisms. Dr. Mercer has contributed to the understanding of antimicrobial susceptibility testing and the therapeutic potential of antimicrobial peptides. He has co-authored publications on topics such as antimicrobial susceptibility testing of peptides and the role of host defense peptides in antifungal therapy.
Shiva Kumar R. Mukkamalla
Shiva Kumar R. Mukkamalla
Hematologist & Oncologist
UPMC Hillman Cancer Center
Indiana Regional Medical Center
USA
Research Interests:
Dr. Mukkamalla's research focuses on hematology and oncology, with particular interest in the management and treatment outcomes of various cancers. His work includes studies on tumor characteristics, treatment modalities, and patient survival rates.
Biography:
Dr. Mukkamalla earned his medical degree and Master of Public Health (MPH). He is a Fellow of the American College of Physicians (FACP) and is affiliated with UPMC Hillman Cancer Center. His clinical expertise encompasses a broad range of oncologic conditions, and he is committed to advancing cancer care through both clinical practice and research.
Shiva Kumar R. Mukkamalla
Sectional Editor (Immunotherapy)
Shiva Kumar R. Mukkamalla
Hematologist & Oncologist
UPMC Hillman Cancer Center
Indiana Regional Medical Center
USA
Research Interests:
Dr. Mukkamalla's research focuses on hematology and oncology, with particular interest in the management and treatment outcomes of various cancers. His work includes studies on tumor characteristics, treatment modalities, and patient survival rates.
Biography:
Dr. Mukkamalla earned his medical degree and Master of Public Health (MPH). He is a Fellow of the American College of Physicians (FACP) and is affiliated with UPMC Hillman Cancer Center. His clinical expertise encompasses a broad range of oncologic conditions, and he is committed to advancing cancer care through both clinical practice and research.
Charlie Bridgewood
Charlie Bridgewood
Scientist, Immunology Research
Almirall, Barcelona
Spain
Research Interests:
- IL-23/IL-17 inflammatory axis
- Novel cytokines in health and disease
- Inflammatory skin diseases
- Inflammatory arthritis
Biography:
Dr. Bridgewood completed his Doctor of Philosophy in Immunology at the University of Bradford. He has contributed significantly to the understanding of cytokine involvement in various inflammatory conditions. His work has been recognized with the Garrod Award from the British Society for Rheumatology, which honors distinguished contributions to the field of rheumatology.
Charlie Bridgewood
Sectional Editor (Inflammatory skin diseases and i
Charlie Bridgewood
Scientist, Immunology Research
Almirall, Barcelona
Spain
Research Interests:
- IL-23/IL-17 inflammatory axis
- Novel cytokines in health and disease
- Inflammatory skin diseases
- Inflammatory arthritis
Biography:
Dr. Bridgewood completed his Doctor of Philosophy in Immunology at the University of Bradford. He has contributed significantly to the understanding of cytokine involvement in various inflammatory conditions. His work has been recognized with the Garrod Award from the British Society for Rheumatology, which honors distinguished contributions to the field of rheumatology.